MET and cancer: Here, we validated a comprehensive targeted cancer gene panel for simultaneous detection of SNVs and indels in 523 cancer-related genes, CNVs of 69 genes, gene fusions of 55 driver genes including exon skipping events in MET and EGFR, and the immunotherapy predictive markers MSI and TMB.